Radiation for Multiple Myeloma in the Era of Novel Agents: Indications, Safety, and Dose Selection
- 12 December 2024
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 35 (1) , 87-98
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Multiple myeloma: 2022 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2022
- Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic CancerJAMA, 2019
- Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myelomaStrahlentherapie und Onkologie, 2017
- Dose escalation of radiotherapy for Metastatic Spinal Cord Compression (MSCC) in patients with relatively favorable survival prognosisStrahlentherapie und Onkologie, 2011
- Total and Single Doses Influence the Effectiveness of Radiotherapy in Palliative Treatment of PlasmacytomaStrahlentherapie und Onkologie, 2008
- Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysisAnnals of Hematology, 2005
- Wertigkeit der Radiotherapie in der Behandlung des multiplen MyelomsStrahlentherapie und Onkologie, 2000
- Is aggressive chemotherapy more effective in the treatment of plasma cell myeloma?European Journal of Cancer and Clinical Oncology, 1989
- Long-term side effects in irradiated patients with Hodgkin's diseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1977
- Bone marrow regeneration and extension after extended field irradiation in Hodgkin's diseaseCancer, 1973